BOSTON – TRIA, a partner-led architecture firm with a focus on science and technology organizations, announced today the completion of a new 12,300 SF headquarters for Oncorus®, Inc., a biotechnology company developing a portfolio of next-generation immunotherapy products to treat several types of cancer.
Located at 50 Hampshire Street in Cambridge, Mass., Oncorus’s new headquarters features an efficient and flexible workspace that supports the company’s scientific research mission and reflects the company’s branding and culture.
“From the beginning of our relationship, TRIA understood how we work and our need for a collaborative work environment,” said Stacy Gilroy, Director, Operations at Oncorus. “TRIA’s design for our lab and office provides an efficiency of space while creating an energy and vibe where employees feel inspired, as well as valued and appreciated, qualities imperative to retaining top talent. We couldn’t be more pleased with our new home.”
The TRIA design team took a holistic approach to the design of Oncorus’s headquarters. The interior designer and lab designer worked closely to design a cohesive integrated space with a variety of work areas, including labs to support highly specific needs, conference rooms for technical presentations, and collaboration areas for impromptu meetings and social interaction. Special attention was paid to the separation of work spaces and work flows in the company’s specialty lab functions. Work stations along the window line allow natural light to penetrate deep into the space, and conference rooms on the interior feature glass walls to offer transparency. One of the conference rooms features a wall-sized window to the company’s lab, providing a view to the exciting scientific discoveries taking place.
Oncorus’s headquarters also includes a versatile kitchen/break area that can accommodate all-company meetings. Specialty design features, such as a rustic-inspired reception desk and a barn door in the kitchen area, bring a stylistic edge and uniqueness to the space. Pops of selective color in the furniture and wall paint convey warmth and energy. Sustainable materials were used wherever possible, including LED lighting with automated controls, recycled materials, and locally sourced products.
Oncorus is a leader in corporate philanthropy and has taken a pledge to donate a portion of product sales revenue to fund promising cancer research and to support cancer care in the developing world.
The Oncorus project team includes:
· Architect: TRIA
· General Contractor: The Richmond Group
· MEP/FP Engineers: AHA Consulting Engineers
· Landlord: BioMed Realty
· Facility Management: Fletcher Martin Corporation
TRIA practices the science of architecture. We combine a deep understanding of the unique needs of science-based organizations with decades of experience constructing spaces and places that enable those organizations to meet their goals. Using a principal-driven approach, we partner closely with clients to enable business success and advance new discoveries, in the lab and across the organization.
Oncorus, Inc., is a biotechnology company developing a portfolio of next-generation immunotherapy products, leveraging its proprietary oncolytic Herpes viruses platform, to treat several types of cancer, including highly malignant and aggressive cancers, based upon the work of renowned scientists Joseph Glorioso III, Ph.D., and Paola Grandi, Ph.D., from the University of Pittsburgh. A leader in corporate philanthropy, Oncorus has taken a pledge to donate a portion of product sales to fund promising cancer research and to support cancer care in the developing world. The company is located in Kendall Square, Cambridge, Massachusetts.
